WallStSmart
YCBD

cbdMD Inc

NYSE MKT: YCBD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.85
-2.02% today

Updated 2026-04-30

Market cap
$10.18M
P/E ratio
1.62
P/S ratio
0.53x
EPS (TTM)
$0.60
Dividend yield
52W range
$0 – $3
Volume
1.8M

cbdMD Inc (YCBD) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-7.7%
Last 4 quarters
Revenue YoY growth
-1.9%
Most recent quarter
EPS YoY growth
+97.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-29.0%
2025-12-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-18$-0.04+33.3%$0.78$0.91+17.3%
2025-12-19$-0.08-14.3%$1.93$1.37-29.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.06$-0.04+33.3%$5.02M-1.9%
2025-09-30$-0.07$-0.08-14.3%$4.72M+3.6%
2025-06-30$-0.16$-0.21-31.2%$4.61M-11.0%
2025-03-31$-1.60$-1.90-18.7%$4.75M+8.5%
2024-12-31$-2.96$-1.76+40.5%$5.11M-4.9%
2024-09-30$-0.45$-0.29+34.8%$4.56M-20.2%
2024-06-30$-0.62$0.08+112.9%$5.17M-15.5%
2024-03-31$-0.75$-0.87-16.0%$4.38M-29.9%
2023-12-31$-0.74$-0.67+9.5%$5.38M
2023-09-30$-0.76$-1.21-59.2%$5.71M
2023-06-30$-0.04$-0.03+25.0%$6.12M
2023-03-31$-0.04$-0.03+25.0%$6.24M

Frequently asked questions

Has cbdMD Inc beaten earnings estimates?
cbdMD Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -7.7% over the last 4 quarters.
How does YCBD stock react to earnings?
YCBD stock has moved an average of -5.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is cbdMD Inc's revenue growth rate?
cbdMD Inc reported year-over-year revenue growth of -1.9% in its most recent quarter, with EPS growing +97.7% year-over-year.